Baymeeva NV - Search Results

1

[The content of N-acetylaspartate in depressed elderly patients during therapy with antidepressants and actovegin].

Miroshnichenko II, Yakovleva OB, Safarova TP, Shipilova ES, Baymeeva NV. Miroshnichenko II, et al. Among authors: baymeeva nv. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(4):38-42. doi: 10.17116/jnevro201911904138. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31156220 Russian.

2

[N-acetylaspartate is a biomarker of psychiatric and neurological disorders].

Baymeeva NV, Miroshnichenko II. Baymeeva NV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(8):94-98. doi: 10.17116/jnevro20151158194-98. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26356622 Review. Russian.

3

[Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation].

Potanin SS, Burminskiy DS, Morozova MA, Platova AI, Baymeeva NV, Miroshnichenko II. Potanin SS, et al. Among authors: baymeeva nv. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(11):40-46. doi: 10.17116/jnevro201511511140-46. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26978050 Russian.

4

Simultaneous Determination of Antipsychotic Drugs and Their Active Metabolites by LC-MS-MS and its Application to Therapeutic Drug Monitoring.

Miroshnichenko II, Baymeeva NV. Miroshnichenko II, et al. Among authors: baymeeva nv. J Chromatogr Sci. 2018 Jul 1;56(6):510-517. doi: 10.1093/chromsci/bmy024. J Chromatogr Sci. 2018. PMID: 29635397

5

[Therapeutic drug monitoring of risperidone and its active metabolite 9-hydroxyrisperidone in the treatment of schizophrenia].

Baymeeva NV, Platova AI, Kaleda VG, Miroshnichenko II. Baymeeva NV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(3):24-28. doi: 10.17116/jnevro201911903124. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31089091 Russian.

6

Haloperidol Reduces the Activity of Complement and Induces the Anti-Inflammatory Transformation of Peritoneal Macrophages in Rats.

Cheremnykh EG, Ivanov PA, Sokolov OY, Prokhorova TA, Tereshkina EB, Baymeeva NV, Miroshnichenko II, Kost NV. Cheremnykh EG, et al. Among authors: baymeeva nv. J Neuroimmune Pharmacol. 2019 Sep;14(3):369-374. doi: 10.1007/s11481-019-09860-3. Epub 2019 Jul 6. J Neuroimmune Pharmacol. 2019. PMID: 31280407

7

Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking Subjects.

Miroshnichenko II, Pozhidaev IV, Ivanova SA, Baymeeva NV. Miroshnichenko II, et al. Among authors: baymeeva nv. Ther Drug Monit. 2020 Apr;42(2):325-329. doi: 10.1097/FTD.0000000000000695. Ther Drug Monit. 2020. PMID: 31425442

8

[Therapeutic drug monitoring of aripiprazole as part of the individualization of the pharmacotherapy of schizophrenia].

Baymeeva NV, Miroshnichenko II, Platova AI, Tikhonov DV, Kaleda VG. Baymeeva NV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):98-103. doi: 10.17116/jnevro202212201198. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 35175709 Russian.

9

[Cinnabarinic acid as a potential prognostic marker of schizophrenia].

Shilov YE, Baymeeva NV, Brusov OS, Oleichik IV, Sizov SV, Tyurin IA. Shilov YE, et al. Among authors: baymeeva nv. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(12):138-142. doi: 10.17116/jnevro2022122121138. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 36537644 Russian.

10

[Therapeutic drug monitoring of antipsychotic drugs in routine psychiatric practice].

Miroshnichenko II, Baymeeva NV, Platova AI, Kaleda VG. Miroshnichenko II, et al. Among authors: baymeeva nv. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(5):145-152. doi: 10.17116/jnevro2023123051145. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37315254 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters